Overview

A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.

Status:
Completed

Trial end date:
2019-05-10

Target enrollment:

Participant gender:

Summary

This is a Phase 1 study to compare the pharmacokinetics of budesonide and albuterol delivered by PT027 compared with PT007 and PT008 administered separately.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Albuterol
Budesonide